Page last updated: 2024-09-03

sulbactam and Cross Infection

sulbactam has been researched along with Cross Infection in 67 studies

Research

Studies (67)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (1.49)	18.7374
1990's	9 (13.43)	18.2507
2000's	27 (40.30)	29.6817
2010's	23 (34.33)	24.3611
2020's	7 (10.45)	2.80

Authors

Authors	Studies
De Luca, F; Docquier, JD; Ide, L; Nordmann, P; Poirel, L; Rossolini, GM; Verlinde, A	1
Fang, X; Huang, F; Wang, J; Yu, J	1
Han, Z; Shen, S; Xiong, Z; Zeng, D	1
Jiang, J; Liu, X; Long, Y; Qiao, L; Wang, Q; Wu, J; Xu, T; Yang, Y; Yu, J; Zhang, B; Zuo, W	1
Assimakopoulos, SF; Christopoulou, I; Dimitriou, G; Gkentzi, D; Mamalis, I; Marangos, M; Paliogianni, F; Tsintoni, A	1
Guclu, E; Karabay, O; Kaya, G; Ogutlu, A	1
Aggarwal, A; Sahu, C; Thomas, KN	1
Cao, J; Chen, L; Liao, W; Xu, W; Xu, Y; Yu, K; Zeng, W; Zhou, T	1
Kulkarni, S; Maddani, S; Munshi, N; Sathe, P	1
Geronilla, GG; Gowd, P; Gupta, A; Lundbye, J; Morris, D; Nair, SU; Patel, N	1
Hsueh, PR; Lee, YT; Tsao, SM	1
Bosnak, VK; Karaoglan, I; Mete, AO; Namiduru, M; Zer, Y	1
Fang, X; Gong, M; Xia, J; Xu, Y; Zhang, D; Zhou, Y	1
Arslan, U; Kus, H; Tuncer, I; Turk Dagi, H	1
Çakmak, BÇ; Engür, D; Eyigör, M; Güzünler, M; Telli, M; Türkmen, MK	1
Kollef, MH; Shorr, AF; Zilberberg, MD	1
Barišić, Z; Goic-Barisic, I; Hrenović, J; Kaliterna, M; Kaliterna, V; Tonkić, M	1
Badal, RE; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S	1
Ikawa, K; Imoto, Y; Matsumoto, K; Morikawa, N; Takeda, Y; Watanabe, E; Yamamoto, H; Yokoyama, Y	1
Carvalheira, A; Casquete, R; Silva, J; Teixeira, P	1
Cevahir, N; Dirgen Caylak, S; Okke, D; Saçar, S; Sayin Kutlu, S; Süzer, T; Turgut, H	1
Hsieh, FC; Lee, CM; Leung, CH; Liu, CP; Wang, NY; Weng, LC	1
Chen, CL; Chia, JH; Chiu, CH; Lee, HY; Liu, SY; Su, LH; Tseng, LY	1
Otük, G; Ozbek, B	1
Mitrokhin, SD; Sokolov, AA	1
Durante-Mangoni, E; Zarrilli, R	1
Herych, ID; Vashchuk, VV	1
Aktas, A; Divrikli, D; Gursoy, T; Ovali, F; Sari, I	1
Altın, N; Argun, C; Canbakan, B; Cesur, S; Koldaş, K; Kurşun, O; Sencan, I; Unal, N	1
Ozseven, AG; Ozseven, L; Sesli Çetin, E	1
Du, W; Liu, Y; Rui, X; Shi, Y; Wang, Y; Xu, YC	1
Berktaş, M; Ceylan, MR; Cıkman, A; Karahocagil, MK; Parlak, M	1
Costa, SF; Levin, AS; Levy, CE; Manrique, AE; Medeiros, EA	1
Dudzevicius, V; Sakalauskas, R; Vitkauskiene, A	1
Rahal, JJ; Segal-Maurer, S; Urban, C	1
Alkan, M; Almog, Y; Borer, A; Gilad, J; Porath, A; Riesenberg, K; Rimar, D; Schlaeffer, F; Smolyakov, R	1
Chen, MJ; Wang, H	1
Mitrokhin, SD	1
Daschner, FD; Frank, U; Mutter, J; Schmidt-Eisenlohr, E	1
Clark, NM; Day, LJ; Malani, PN; Pagani, FD; Singal, A	1
Sandri, AM; Zavascki, AP	1
Danziger, LH; Jain, R	1
Bachinskaia, EN; Beloborodova, NV; Kuznetsova, ST; Popov, DA; Vostrikov, TIu	1
Das, BK; Dhawan, B; Kapil, A; Mohanty, S; Singhal, R; Sood, S	1
Betrosian, AP; Frantzeskaki, F; Georgiadis, G; Xanthaki, A	1
Cassone, A; Di Sora, F; Dionisi, AM; Gallo, S; Longo, B; Luzzi, I; Monaco, M; Montella, F; Pantosti, A; Placanica, P; Rezza, G; Tarasi, A; Volpe, I	1
Cherkashin, EA; Galeeva, EV; Ivanov, DV; Krapivina, IV; Sidorenko, SV; Veshutova, NS	1
Peleg, AY	1
Pachón, J; Vila, J	1
Costa, SF; Grinbaum, RS; Levin, AS; Oliveira, MS; Prado, GV	1
Kostakis, A; Lachanas, E; Miyakis, S; Sfyras, N; Tomos, P	1
Bernaldo de Quirós, JF; Moreno Torrico, A; Ruiz Palomar, J; Telenti Asensio, M	1
Burns, J; Eisner, W; Go, ES; Kreiswirth, B; Mariano, N; Mosinka-Snipas, K; Rahal, JJ; Urban, C	1
Avraham, I; Berger, BJ; Go, E; Mariano, N; Rahal, JJ; Rubin, D; Urban, C	1
Cheong, YM; Lim, VK	1
Becerril, B; Jiménez-Mejías, ME; Pachón, J; Palomino-Nicás, J; Revuelta, M; Rodríguez-Cobacho, A	1
Ardanuy, C; Ariza, J; Corbella, X; Gudiol, F; Pujol, M; Sora, M; Tubau, F; Vuelta, M	1
Carmeli, Y; Gold, H; Harris, AD; Kaye, KS	1
Miranda, E; Sader, HS; Sejas, L; Tosin, I	1
Kestner, M; Kirton, OC; O'Neill, PA; Tortella, BJ	1
Carmeli, Y; Castro, J; Eliopoulos, GM; Samore, MH	1
Bisson, G; Edelstein, PH; Fishman, NO; Lautenbach, E; Patel, JB	1
Casiraghi, S; Caspani, P; Germiniani, R; Pace, M; Trabucchi, E	1
Edwards, GF; Lindsay, G; Taylor, EW	1
Hatala, M; Modr, Z; Sechser, T; Svácek, J	1
Botta, GA; Pesce, A; Schito, GC; Sessarego, FV	1

Reviews

6 review(s) available for sulbactam and Cross Infection

Article	Year
Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance. Future microbiology, 2011, Volume: 6, Issue:4 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Colistin; Cross Infection; DNA Fingerprinting; DNA, Ribosomal Spacer; Drug Resistance, Multiple, Bacterial; Humans; Infection Control; Molecular Epidemiology; RNA, Ribosomal, 16S; Sulbactam	2011
[Modern possibilities of hepacef combi (cefoperazon/sulbactam) application for the treatment of surgical infection]. Klinichna khirurhiia, 2011, Issue:2 Topics: Anti-Bacterial Agents; Cefoperazone; Cross Infection; Drug Combinations; Humans; Sulbactam; Surgical Wound Infection	2011
Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians. The Annals of pharmacotherapy, 2004, Volume: 38, Issue:9 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Colistin; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Humans; Randomized Controlled Trials as Topic; Risk Factors; Sulbactam; Tetracyclines	2004
Optimizing therapy for Acinetobacter baumannii. Seminars in respiratory and critical care medicine, 2007, Volume: 28, Issue:6 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Intensive Care Units; Minocycline; Polymyxins; Sulbactam; Tigecycline	2007
Therapeutic options for Acinetobacter baumannii infections. Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:4 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Minocycline; Patient Selection; Rifampin; Sulbactam; Tigecycline; Treatment Outcome	2008
Acinetobacter baumannii mediastinitis after cardiopulmonary bypass: case report and literature review. Surgical infections, 2008, Volume: 9, Issue:2 Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Cardiopulmonary Bypass; Cross Infection; Debridement; Female; Humans; Mediastinitis; Middle Aged; Sulbactam; Surgical Wound Infection	2008

Trials

4 trial(s) available for sulbactam and Cross Infection

Article	Year
High-dose ampicillin-sulbactam as an alternative treatment of late-onset VAP from multidrug-resistant Acinetobacter baumannii. Scandinavian journal of infectious diseases, 2007, Volume: 39, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Ampicillin; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Cross Infection; Disk Diffusion Antimicrobial Tests; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Middle Aged; Pneumonia, Ventilator-Associated; Sulbactam; Treatment Outcome	2007
Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii. The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:6 Topics: Acinetobacter; Acinetobacter Infections; Aged; Ampicillin; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Sulbactam; Treatment Outcome	1998
Perioperative antibiotic use in high-risk penetrating hollow viscus injury: a prospective randomized, double-blind, placebo-control trial of 24 hours versus 5 days. The Journal of trauma, 2000, Volume: 49, Issue:5 Topics: Adult; Ampicillin; Analysis of Variance; Anti-Bacterial Agents; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Injury Severity Score; Logistic Models; Male; Penicillins; Perioperative Care; Prospective Studies; Risk Factors; Sulbactam; Surgical Wound Infection; Time Factors; Viscera; Wounds, Penetrating	2000
[Sulbactam-ampicillin in surgery. Our experience]. Minerva chirurgica, 1992, Oct-31, Volume: 47, Issue:20 Topics: Adult; Aged; Ampicillin; Cross Infection; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Sulbactam; Surgical Procedures, Operative; Time Factors	1992

Other Studies

57 other study(ies) available for sulbactam and Cross Infection

Article	Year
BEL-2, an extended-spectrum beta-lactamase with increased activity toward expanded-spectrum cephalosporins in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1 Topics: Belgium; beta-Lactamases; Cephalosporinase; Cephalosporins; Cross Infection; Escherichia coli; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2010
Investigation and Analysis of Infection among Inpatients in a Tertiary Hospital in Shanghai. Computational and mathematical methods in medicine, 2022, Volume: 2022 Topics: Adult; Anti-Bacterial Agents; Cefoperazone; China; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Humans; Inpatients; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Retrospective Studies; Sulbactam; Tertiary Care Centers	2022
The Investigation on Nosocomial Infection of Acinetobacter baumannii and the Clinical Analysis of Sequential Therapy of Cefoperazone/Sulbactam Sodium for Intracranial Infection. Computational and mathematical methods in medicine, 2022, Volume: 2022 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Case-Control Studies; Cefoperazone; Cross Infection; Humans; Retrospective Studies; Sodium; Sulbactam; Tigecycline	2022
Clinical outcomes and safety of intravenous polymyxin B-based treatment in critically ill patients with carbapenem-resistant Acinetobacter baumannii nosocomial pneumonia. International journal of antimicrobial agents, 2023, Volume: 62, Issue:2 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Critical Illness; Cross Infection; Healthcare-Associated Pneumonia; Humans; Polymyxin B; Retrospective Studies; Sulbactam; Tigecycline	2023
Extensively-drug resistant Journal of chemotherapy (Florence, Italy), 2020, Volume: 32, Issue:2 Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacteremia; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Retrospective Studies; Sulbactam	2020
The effect of cefoperazone sulbactam and piperacillin tazobactam on mortality in Gram-negative nosocomial infections. Journal of chemotherapy (Florence, Italy), 2020, Volume: 32, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefoperazone; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sulbactam	2020
Ralstonia mannitolilytica bacteraemia and gastroenteritis in a patient with rheumatoid arthritis: an emerging nosocomial infection. Rheumatology (Oxford, England), 2021, 06-18, Volume: 60, Issue:6 Topics: Anti-Bacterial Agents; Arthritis, Rheumatoid; Bacteremia; Cefoperazone; Cross Infection; Diarrhea; Female; Gastroenteritis; Gram-Negative Bacterial Infections; Humans; Middle Aged; Ralstonia; Sulbactam	2021
Bloodstream infections caused by ST2 Acinetobacter baumannii: risk factors, antibiotic regimens, and virulence over 6 years period in China. Antimicrobial resistance and infection control, 2021, 01-18, Volume: 10, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefoperazone; China; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Respiration, Artificial; Retrospective Studies; Risk Factors; Sepsis; Sulbactam; Thrombocytopenia; Tigecycline; Virulence; Young Adult	2021
Management of ventilator associated pneumonia with a new antibiotic adjuvant entity (ceftriaxone+sulbactam+disodium edetate) - A novel approach to spare carbapenems. Journal of critical care, 2017, Volume: 41 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Ceftriaxone; Chemotherapy, Adjuvant; Colistin; Cross Infection; Drug Therapy, Combination; Edetic Acid; Female; Humans; Intensive Care Units; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Retrospective Studies; Sulbactam; Thienamycins	2017
Central line associated blood stream infection related to cooling catheter in cardiac arrest survivors undergoing therapeutic hypothermia by endovascular cooling. Connecticut medicine, 2013, Volume: 77, Issue:1 Topics: Aged; Ampicillin; Anti-Bacterial Agents; Catheter-Related Infections; Catheterization, Central Venous; Cross Infection; Endovascular Procedures; Female; Heart Arrest; Humans; Hypothermia, Induced; Male; Middle Aged; Retrospective Studies; Sepsis; Sulbactam	2013
Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2013, Volume: 32, Issue:9 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Cilastatin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Minocycline; Piperacillin; Sulbactam; Tigecycline; Treatment Outcome	2013
In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii. The Journal of international medical research, 2013, Volume: 41, Issue:6 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Carbapenems; Cefoperazone; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Tigecycline	2013
A retrospective analysis of carbapenem-resistant Acinetobacter baumannii-mediated nosocomial pneumonia and the in vitro therapeutic benefit of cefoperazone/sulbactam. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2014, Volume: 23 Topics: Acinetobacter baumannii; Aged; Aged, 80 and over; Anti-Bacterial Agents; C-Reactive Protein; Carbapenems; Cefoperazone; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Humans; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Minocycline; Pneumonia, Bacterial; Retrospective Studies; Sulbactam; Thienamycins	2014
[In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates]. Mikrobiyoloji bulteni, 2014, Volume: 48, Issue:2 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cefoperazone; Cross Infection; Drug Combinations; Drug Synergism; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Sulbactam; Thienamycins	2014
A milk pump as a source for spreading Acinetobacter baumannii in a neonatal intensive care unit. Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine, 2014, Volume: 9, Issue:10 Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Breast Milk Expression; Cross Infection; Disease Outbreaks; Disease Reservoirs; Equipment Contamination; Humans; Incidence; Infant, Newborn; Infection Control; Intensive Care Units, Neonatal; Male; Meropenem; Microbial Sensitivity Tests; Respiratory Distress Syndrome, Newborn; Sulbactam; Thienamycins	2014
Secular trends in Acinetobacter baumannii resistance in respiratory and blood stream specimens in the United States, 2003 to 2012: A survey study. Journal of hospital medicine, 2016, Volume: 11, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Humans; Intensive Care Units; Microbial Sensitivity Tests; Respiratory Tract Infections; Sulbactam; Surveys and Questionnaires; Trimethoprim, Sulfamethoxazole Drug Combination; United States	2016
Acinetobacter baumannii in Southern Croatia: clonal lineages, biofilm formation, and resistance patterns. Infectious diseases (London, England), 2015, Volume: 47, Issue:12 Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Biofilms; Carbapenems; Croatia; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Intensive Care Units; Microbial Sensitivity Tests; Monte Carlo Method; Respiratory System; Respiratory Tract Infections; Sulbactam; Urine; Wounds and Injuries	2015
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Gene Expression; Humans; Imipenem; Intraabdominal Infections; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam	2016
Pharmacokinetics of Prophylactic Ampicillin-Sulbactam and Dosing Optimization in Patients Undergoing Cardiovascular Surgery with Cardiopulmonary Bypass. Biological & pharmaceutical bulletin, 2015, Volume: 38, Issue:11 Topics: Aged; Ampicillin; Anti-Bacterial Agents; Cardiopulmonary Bypass; Cross Infection; Drug Administration Schedule; Female; Half-Life; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus; Sulbactam	2015
Prevalence and antimicrobial susceptibility of Acinetobacter spp. isolated from meat. International journal of food microbiology, 2017, Feb-21, Volume: 243 Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Animals; Anti-Bacterial Agents; Cattle; Ceftazidime; Chickens; Ciprofloxacin; Cross Infection; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence; Red Meat; Sulbactam; Swine; Trimethoprim, Sulfamethoxazole Drug Combination	2017
[Successful treatment of a patient with multidrug resistant Acinetobacter baumannii meningitis with high dose ampicillin-sulbactam]. Mikrobiyoloji bulteni, 2008, Volume: 42, Issue:2 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Ampicillin; Anti-Bacterial Agents; Cerebrospinal Fluid; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Sulbactam; Treatment Outcome	2008
Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2008, Volume: 41, Issue:6 Topics: Aged; Aged, 80 and over; Amikacin; Anti-Infective Agents; Bacteremia; Ceftazidime; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals, Teaching; Humans; Infection Control; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Sulbactam; Taiwan	2008
Mechanisms of resistance to ciprofloxacin, ampicillin/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in Taiwan. International journal of antimicrobial agents, 2010, Volume: 35, Issue:4 Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Gene Expression; Humans; Imipenem; Integrons; Point Mutation; Polymerase Chain Reaction; Sequence Analysis, DNA; Sulbactam; Taiwan	2010
In vitro activities of tigecycline alone and in combination with colistin sulfate or sulbactam against carbapenem-susceptible and -resistant Acinetobacter baumannii strains isolated from Intensive Care Units. International journal of antimicrobial agents, 2010, Volume: 36, Issue:2 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Drug Resistance, Bacterial; Drug Synergism; Humans; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Minocycline; Sulbactam; Thienamycins; Tigecycline	2010
[Amoxycillin/Sulbactam (Trifamox IBL) in prophylaxis and therapy of surgical site infections in oncologic patients]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2010, Volume: 55, Issue:7-8 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacteria; Cross Infection; Drug Combinations; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Sulbactam; Surgical Wound Infection	2010
Use of cefoperazone/sulbactam in neonates. Pediatrics international : official journal of the Japan Pediatric Society, 2012, Volume: 54, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Male; Microbial Sensitivity Tests; Sulbactam	2012
[A case of ventilator-associated pneumonia due to Pantoea agglomerans]. Mikrobiyoloji bulteni, 2012, Volume: 46, Issue:2 Topics: Anti-Bacterial Agents; Cefoperazone; Cross Infection; Drug Therapy, Combination; Enterobacteriaceae Infections; Heart Arrest; Humans; Kidney Failure, Chronic; Male; Middle Aged; Ofloxacin; Opportunistic Infections; Pantoea; Pneumonia, Ventilator-Associated; Respiration, Artificial; Sulbactam	2012
[Do different interpretative methods used for evaluation of checkerboard synergy test affect the results?]. Mikrobiyoloji bulteni, 2012, Volume: 46, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Sulbactam; Thienamycins	2012
[Cefoperazone-sulbactam plus minocycline in the treatment of extensively drug resistant Acinetobacter infections]. Zhonghua yi xue za zhi, 2012, Oct-30, Volume: 92, Issue:40 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Cefoperazone; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Minocycline; Prospective Studies; Sulbactam	2012
[Evaluation of Colistin-Ampicillin/Sulbactam Combination Efficacy in Imipenem-Resistant Acinetobacter baumannii Strains]. Mikrobiyoloji bulteni, 2013, Volume: 47, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Imipenem; Microbial Sensitivity Tests; Sulbactam	2013
Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam. International journal of antimicrobial agents, 2003, Volume: 21, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Child; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Sulbactam	2003
[The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests]. Medicina (Kaunas, Lithuania), 2003, Volume: 39, Issue:3 Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bronchoalveolar Lavage Fluid; Ceftazidime; Cefuroxime; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fusidic Acid; Gentamicins; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Staphylococcus aureus; Sulbactam; Vancomycin Resistance	2003
Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, May-15, Volume: 36, Issue:10 Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple; Drug Synergism; Drug Therapy, Combination; Humans; Infection Control; Polymyxin B; Sulbactam	2003
Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment. The Journal of hospital infection, 2003, Volume: 54, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Ampicillin; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Hospital Bed Capacity, 500 and over; Humans; Intensive Care Units; Israel; Male; Medical Records; Microbial Sensitivity Tests; Middle Aged; Outcome Assessment, Health Care; Polymerase Chain Reaction; Retrospective Studies; Risk Factors; Sulbactam	2003
[Changes of antimicrobial resistance among nonfermenting gram-negative bacilli isolated from intensive care units from 1994 to 2001 in China]. Zhonghua yi xue za zhi, 2003, Mar-10, Volume: 83, Issue:5 Topics: Anti-Bacterial Agents; Cefoperazone; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Intensive Care Units; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Sulbactam	2003
[Sulperazone in the treatment of severe infections in patients with cancer]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2003, Volume: 48, Issue:3 Topics: Anti-Bacterial Agents; Cefoperazone; Cross Infection; Drug Combinations; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Neoplasms; Pneumonia, Bacterial; Sulbactam; Surgical Wound Infection; Urinary Tract Infections	2003
Comparative in vitro activity of piperacillin, piperacillin-sulbactam and piperacillin-tazobactam against nosocomial pathogens isolated from intensive care patients. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2003, Volume: 9, Issue:11 Topics: Anti-Bacterial Agents; Cross Infection; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam	2003
Roseomonas infection associated with a left ventricular assist device. Infection control and hospital epidemiology, 2003, Volume: 24, Issue:12 Topics: Ampicillin; Anti-Bacterial Agents; Aortic Valve Insufficiency; Cardiomyopathies; Cefuroxime; Cross Infection; Drug Resistance; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Heart Transplantation; Heart-Assist Devices; Humans; Methylobacteriaceae; Michigan; Middle Aged; Sulbactam	2003
Restricting the use of ampicillin-sulbactam. The Journal of hospital infection, 2004, Volume: 56, Issue:2 Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Brazil; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Drug Utilization Review; Humans; Infection Control; Sulbactam	2004
[Clinical experience with the treatment of severe nosocomial infections by inhibitor-protected 3rd generation cephalosporin cefoperazone/sulbactam]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2005, Volume: 50, Issue:4 Topics: Adult; Anti-Bacterial Agents; Cefoperazone; Child; Child, Preschool; Cross Infection; Drug Combinations; Gram-Negative Bacteria; Humans; Infant; Male; Middle Aged; Postoperative Complications; Sulbactam	2005
Comparative in vitro activity of beta-lactam/beta-lactamase inhibitor combinations against gram negative bacteria. The Indian journal of medical research, 2005, Volume: 122, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Cefoperazone; Clavulanic Acids; Cross Infection; Gram-Negative Bacteria; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Ticarcillin	2005
[Three-year experience with the use of cefoperazone/sulbactam (sulperazone) in the treatment of hospital-acquired infections in an oncologic hospital]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2006, Volume: 51, Issue:1 Topics: Anti-Infective Agents; Candida; Cefoperazone; Cross Infection; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Oncology Service, Hospital; Sulbactam	2006
Molecular findings and antibiotic-resistance in an outbreak of Acinetobacter baumannii in an intensive care unit. Annali dell'Istituto superiore di sanita, 2007, Volume: 43, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Carbapenems; Colistin; Cross Infection; Disease Outbreaks; Disinfection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Intensive Care Units; Male; Middle Aged; Patient Isolation; Rifampin; Rome; Sulbactam	2007
[Resistance epidemiology of gramnegative nonfermenting pathogens of nosocomial infections in intensive care units and surgical departments]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2006, Volume: 51, Issue:7 Topics: Acinetobacter baumannii; Adolescent; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefoperazone; Child; Child, Preschool; Cross Infection; Drug Resistance, Microbial; Genes, Bacterial; Gram-Negative Bacterial Infections; Humans; Infant; Intensive Care Units; Microbial Sensitivity Tests; Molecular Epidemiology; Moscow; Pseudomonas aeruginosa; Sulbactam; Surgery Department, Hospital	2006
Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp. The Journal of antimicrobial chemotherapy, 2008, Volume: 61, Issue:6 Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Ampicillin; APACHE; beta-Lactam Resistance; Bronchoalveolar Lavage Fluid; Carbapenems; Child; Child, Preschool; Cross Infection; Female; Hospitals, Teaching; Humans; Infant; Logistic Models; Male; Middle Aged; Multivariate Analysis; Polymyxins; Prognosis; Renal Insufficiency; Retrospective Studies; Risk Factors; Shock, Septic; Sulbactam; Time Factors; Treatment Outcome	2008
[The efficacy of sulbactam-ampicillin in a urinary infection due to Acinetobacter calcoaceticus var. anitratus]. Medicina clinica, 1995, Oct-07, Volume: 105, Issue:11 Topics: Acinetobacter calcoaceticus; Acinetobacter Infections; Ampicillin; Cross Infection; Drug Evaluation; Drug Therapy, Combination; Humans; Prospective Studies; Sulbactam; Urinary Tract Infections	1995
Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet (London, England), 1994, Nov-12, Volume: 344, Issue:8933 Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Cross Infection; Disease Outbreaks; DNA, Bacterial; Environmental Microbiology; Humans; Imipenem; Microbial Sensitivity Tests; Middle Aged; New York; Polymyxin B; Sulbactam	1994
Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus. The Journal of infectious diseases, 1993, Volume: 167, Issue:2 Topics: Acinetobacter calcoaceticus; Acinetobacter Infections; Ampicillin; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Imipenem; Microbial Sensitivity Tests; Retrospective Studies; Sulbactam	1993
In-vitro activity of cefoperazone-sulbactam combination against cefoperazone resistant clinical isolates in a Malaysian general hospital. The Malaysian journal of pathology, 1995, Volume: 17, Issue:2 Topics: Cefoperazone; Cephalosporin Resistance; Cross Infection; Drug Combinations; Gram-Negative Bacterial Infections; Hospitals, General; Malaysia; Sulbactam	1995
Treatment of multidrug-resistant Acinetobacter baumannii meningitis with ampicillin/sulbactam. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24, Issue:5 Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Ampicillin; Cross Infection; Drug Resistance, Multiple; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Humans; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Sulbactam; Survival Rate; Treatment Outcome	1997
Risk factors for recovery of ampicillin-sulbactam-resistant Escherichia coli in hospitalized patients. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:4 Topics: Aged; Ampicillin; Ampicillin Resistance; Analysis of Variance; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Models, Theoretical; Penicillins; Risk Factors; Sex Factors; Sulbactam	2000
Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2000, Volume: 4, Issue:1 Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Clavulanic Acid; Cross Infection; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam; Ticarcillin	2000
Clinical isolation and resistance patterns of and superinfection with 10 nosocomial pathogens after treatment with ceftriaxone versus ampicillin-sulbactam. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:1 Topics: Aged; Ampicillin; Anti-Bacterial Agents; Bacteria; Ceftriaxone; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillins; Regression Analysis; Sulbactam; Superinfection; Survival Analysis	2001
Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence. Infection control and hospital epidemiology, 2002, Volume: 23, Issue:5 Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Carrier State; Case-Control Studies; Cefepime; Cephalosporins; Cross Infection; Drug Therapy, Combination; Drug Utilization Review; Escherichia coli Infections; Feces; Female; Formularies, Hospital as Topic; Gentamicins; Hospitals, Community; Hospitals, Urban; Humans; Infection Control; Klebsiella Infections; Length of Stay; Male; Middle Aged; Pennsylvania; Prevalence; Risk Factors; Sulbactam	2002
A bacteriological assessment of ampicillin with sulbactam as antibiotic prophylaxis in patients undergoing biliary tract operations. The West of Scotland Surgical Infection Study Group. The Journal of hospital infection, 1990, Volume: 16, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Bacterial Infections; Biliary Tract Surgical Procedures; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Enterococcus faecalis; Female; Humans; Male; Middle Aged; Postoperative Complications; Premedication; Prospective Studies; Risk Factors; Sulbactam	1990
[Unasyn in severe hospital infections]. Casopis lekaru ceskych, 1991, May-24, Volume: 130, Issue:14 Topics: Acute Disease; Adult; Aged; Ampicillin; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Sulbactam; Surgical Wound Infection	1991
Antibacterial activity of the sulbactam-ampicillin combination. Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:6 Topics: Ampicillin; Bacteria; beta-Lactamases; Cross Infection; Drug Therapy, Combination; Microbial Sensitivity Tests; Sulbactam	1989